1 / 1

Duchenne Muscular Dystrophy Market

The market size of Duchenne Muscular Dystrophy in the 7 MM was found to be USD 266.06 Million in 2017. The United States accounts for the largest Duchenne Muscular Dystrophy (DMD) market size in comparison to EU5 and Japan.<br>The total diagnosed DMD prevalent population in 2017 was 27,685 (in 7MM).<br><br>The key players in Duchenne Muscular Dystrophy Markt include Sarepta Therapeutics, Santhera Pharmaceuticals, Italfarmaco, Catabasis Pharmaceuticals, NS Pharma, Pfizer, Taiho Pharmaceutical, FibroGen, Daiichi Sankyo, Hoffmann-La Roche, Nobelpharma, Cumberland Pharma, and many others.<br><br>For more details visit: https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market#infographics<br><br>#Duchenne Muscular Dystrophy #Duchenne Muscular Dystrophy Market #Duchenne Muscular Dystrophy Epidemiology #Duchenne Muscular Dystrophy key companies #Duchenne Muscular Dystrophy market size #DMD<br><br>

DelveInsight
Download Presentation

Duchenne Muscular Dystrophy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related